Literature DB >> 27155530

Treatment of alcohol use disorders in patients with alcoholic liver disease.

Giovanni Addolorato1, Antonio Mirijello2, Pablo Barrio3, Antoni Gual4.   

Abstract

Alcohol use disorders (AUDs) is one of the leading causes of disease and disability in almost all European countries. Among the alcohol-related diseases, alcoholic liver disease (ALD) is the most common. At present, alcohol is the most frequent cause of liver cirrhosis in the Western world. The cornerstone of treatment for ALD is achieving total alcohol abstinence and preventing relapse; medical and surgical treatments for ALD are limited when drinking continues. This narrative review summarizes current treatments for AUDs with a particular emphasis to the treatment of AUDs in patients with ALD. Medical management, psychosocial and pharmacological interventions are analyzed, underlying limits and options in AUD patients. Finally, this review discusses the most appropriate setting for the management of AUD patients with advanced liver disease as well as the indications for liver transplantation in AUD patients.
Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol relapse prevention; Alcohol use disorders; Alcoholic liver disease; Liver cirrhosis; Liver transplantation; Pharmacological interventions; Psychosocial interventions

Mesh:

Year:  2016        PMID: 27155530     DOI: 10.1016/j.jhep.2016.04.029

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  49 in total

Review 1.  Treating Alcohol Use Disorder in Chronic Liver Disease.

Authors:  Eric R Yoo; George Cholankeril; Aijaz Ahmed
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-26

2.  Epidemiological Realities of Alcoholic Liver Disease: Global Burden, Research Trends, and Therapeutic Promise.

Authors:  Jia Xiao; Fei Wang; Nai-Kei Wong; Yi Lv; Yingxia Liu; Jiajun Zhong; Shuaiyin Chen; Wei Li; Kazuo Koike; Xiaowei Liu; Hua Wang
Journal:  Gene Expr       Date:  2020-07-20

Review 3.  Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease.

Authors:  Lorenzo Leggio; Mary R Lee
Journal:  Am J Med       Date:  2016-10-29       Impact factor: 4.965

4.  Alcohol-related liver disease: Time for action.

Authors:  Ramon Bataller; Gavin E Arteel; Christophe Moreno; Vijay Shah
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 5.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

6.  4-O'-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in mice.

Authors:  Eleonora Patsenker; Andrea Chicca; Vanessa Petrucci; Sheida Moghadamrad; Andrea de Gottardi; Jochen Hampe; Jürg Gertsch; Nasser Semmo; Felix Stickel
Journal:  J Mol Med (Berl)       Date:  2017-07-08       Impact factor: 4.599

7.  Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.

Authors:  Neil D Shah; Meritxell Ventura-Cots; Juan G Abraldes; Mohamed Alboraie; Ahmad Alfadhli; Josepmaria Argemi; Ester Badia-Aranda; Enrique Arús-Soler; A Sidney Barritt; Fernando Bessone; Marina Biryukova; Flair J Carrilho; Marlen Castellanos Fernández; Zaily Dorta Guiridi; Mohamed El Kassas; Teo Eng-Kiong; Alberto Queiroz Farias; Jacob George; Wenfang Gui; Prem H Thurairajah; John Chen Hsiang; Azra Husić-Selimovic; Vasily Isakov; Mercy Karoney; Won Kim; Johannes Kluwe; Rakesh Kochhar; Narendra Dhaka; Pedro Marques Costa; Mariana A Nabeshima Pharm; Suzane K Ono; Daniela Reis; Agustina Rodil; Caridad Ruenes Domech; Federico Sáez-Royuela; Christoph Scheurich; Way Siow; Nadja Sivac-Burina; Edna Solange Dos Santos Traquino; Fatma Some; Sanjin Spreckic; Shiyun Tan; Julio Vorobioff; Andrew Wandera; Pengbo Wu; Mohamed Yacoub; Ling Yang; Yuanjie Yu; Nerma Zahiragic; Chaoqun Zhang; Helena Cortez-Pinto; Ramon Bataller
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-29       Impact factor: 11.382

8.  Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent Patients.

Authors:  Vatsalya Vatsalya; Akash Pandey; Melanie L Schwandt; Matthew C Cave; Shirish S Barve; Vijay A Ramchandani; Craig J McClain
Journal:  Clin Drug Investig       Date:  2016-11       Impact factor: 2.859

9.  Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis.

Authors:  Shari Rogal; Ada Youk; Hongwei Zhang; Walid F Gellad; Michael J Fine; Chester B Good; Maggie Chartier; Andrea DiMartini; Timothy Morgan; Ramon Bataller; Kevin L Kraemer
Journal:  Hepatology       Date:  2020-05-22       Impact factor: 17.425

10.  Attacking Alcohol-Related Liver Disease by Taxing Alcohol Sales.

Authors:  Elliot B Tapper; Neehar D Parikh; Suthat Liangpunsakul
Journal:  Alcohol Clin Exp Res       Date:  2020-12-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.